These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2648356)

  • 21. Starting insulin therapy in type 2 diabetes: lesson 2.
    McCall AL
    Curr Diab Rep; 2005 Oct; 5(5):326-8. PubMed ID: 16188165
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diabetes, sport and exercise].
    Fischer H
    Clin Res Cardiol Suppl; 2011 May; 6():6-9. PubMed ID: 22528172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacological treatment of hyperglycemia in NIDDM. American Diabetes Association.
    Diabetes Care; 1995 Nov; 18(11):1510-8. PubMed ID: 8722084
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes.
    Welsh JB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S242-S249. PubMed ID: 29916736
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of inhaled insulin on fasting and postprandial plasma glucose.
    Mikhail NE; Wali S; Cope D
    Ann Intern Med; 2007 Jun; 146(11):821; author reply 821-2. PubMed ID: 17548418
    [No Abstract]   [Full Text] [Related]  

  • 26. Starting insulin therapy for type-2 diabetes.
    Harbuwono DS
    Acta Med Indones; 2010 Apr; 42(2):116-20. PubMed ID: 20513939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 28. Ten errors to avoid in managing type 2 diabetes. Getting back to the basics.
    Trachtenbarg DE
    Postgrad Med; 1998 Aug; 104(2):35-9, 43. PubMed ID: 9721577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comment on Home et al. Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes care 2014;37:1499-1508.
    Conget I; Aronson R; Lee S; Cohen O; Reznik Y
    Diabetes Care; 2014 Nov; 37(11):e245-6. PubMed ID: 25342842
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin degludec/liraglutide (Xultophy 100/3.6) for type 2 diabetes.
    Med Lett Drugs Ther; 2017 Sep; 59(1529):147-149. PubMed ID: 28880845
    [No Abstract]   [Full Text] [Related]  

  • 31. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
    Gudat U; Bungert S; Kemmer F; Heinemann L
    Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoglycaemia: costs, insulins and prevention.
    Holt RI
    Diabet Med; 2016 Apr; 33(4):419-20. PubMed ID: 26995756
    [No Abstract]   [Full Text] [Related]  

  • 33. Type II diabetes: insulin versus oral agents.
    Martin DB
    N Engl J Med; 1986 May; 314(20):1314-5. PubMed ID: 3517646
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination therapy with new targets in Type 2 diabetes: a review of available agents with a focus on pre-exercise adjustment.
    McDonnell ME
    J Cardiopulm Rehabil Prev; 2007; 27(4):193-201. PubMed ID: 17667012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous Glucose Monitoring in 2017.
    Battelino T; Bode BW
    Diabetes Technol Ther; 2018 Feb; 20(S1):S13-S29. PubMed ID: 29437476
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of type 2 diabetes: one extreme to another.
    Zaidi S
    Arch Intern Med; 2009 Jul; 169(13):1246-7; author reply 1247. PubMed ID: 19597079
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
    Bressler R; Johnson DG
    Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment options for paediatric diabetes.
    Verrotti A; Chiuri RM; Blasetti A; Mohn A; Chiarelli F
    Expert Opin Pharmacother; 2010 Oct; 11(15):2483-95. PubMed ID: 20666700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved insulin sensitivity and metabolic control in type 2 diabetes does not influence plasma homocysteine.
    Pouwels MJ; Den Heijer M; Blom HJ; Tack CJ; Hermus AR
    Diabetes Care; 2003 May; 26(5):1637-9. PubMed ID: 12716838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.